• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉高压症对肝内胆管细胞癌肝切除术后短期和长期结局的影响:倾向评分匹配分析。

Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.

机构信息

Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.

The Big Data Institute of Southeast Hepatobiliary Health Information, Fuzhou, China.

出版信息

Cancer Med. 2021 Oct;10(20):6985-6997. doi: 10.1002/cam4.4222. Epub 2021 Aug 18.

DOI:10.1002/cam4.4222
PMID:34405567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8525133/
Abstract

OBJECTIVE

We explored the impact of clinically significant portal hypertension (CSPH) on short- and long-term outcomes of intrahepatic cholangiocarcinoma (ICC) after liver resection (LR).

METHODS

Data of 352 ICC patients with cirrhosis who underwent LR were extracted from the Primary Liver Cancer Big Data (PLCBD) between 2005 and 2015 and reviewed. A nomogram based on logistic analyses was developed to illustrate the influencing factors of post-hepatectomy liver failure (PHLF). The impact of CSPH on long-term survival was explored through propensity score matching (PSM) analysis, log-rank test, Cox proportional hazards model, and Kaplan-Meier curves.

RESULTS

A total of 106 patients had CSPH, and 246 patients did not. A nomogram established based on GGT level, CSPH, intraoperative blood loss, and multiple tumors had an area under the receiver operating characteristic curve of 0.721 (95% confidence interval [CI] = 0.630-0.812), which displayed a better PHLF predictive value than the MELD score (0.639, 95% CI = 0.532-0.747) and Child-Pugh score (0.612, 95% CI = 0.506-0.719). Moreover, the patients with CSPH had worse overall survival (OS) rates than the patients without CSPH in the whole cohort (p = 0.011) and PSM cohort (p = 0.017). After PSM, multivariable Cox analyses identified that CSPH was an independent risk factor for OS (hazard ratio = 1.585, 95% CI = 1.107-2.269; p = 0.012).

CONCLUSION

CSPH is a significant risk factor for PHLF and OS in ICC patients with cirrhosis after surgery. Selecting the proper patients before operation can effectively avoid PHLF and improve the prognosis of ICC.

摘要

目的

探讨临床显著门静脉高压(CSPH)对肝切除(LR)后肝内胆管细胞癌(ICC)短期和长期结局的影响。

方法

从 2005 年至 2015 年,从原发性肝癌大数据(PLCBD)中提取了 352 例肝硬化 ICC 患者的 LR 数据进行回顾性分析。基于逻辑分析建立列线图,说明肝切除术后肝衰竭(PHLF)的影响因素。通过倾向评分匹配(PSM)分析、对数秩检验、Cox 比例风险模型和 Kaplan-Meier 曲线探讨 CSPH 对长期生存的影响。

结果

共 106 例患者存在 CSPH,246 例患者不存在 CSPH。基于 GGT 水平、CSPH、术中出血量和多发肿瘤建立的列线图,其受试者工作特征曲线下面积为 0.721(95%置信区间 [CI] 0.630-0.812),预测 PHLF 的价值优于 MELD 评分(0.639,95%CI 0.532-0.747)和 Child-Pugh 评分(0.612,95%CI 0.506-0.719)。此外,整个队列(p=0.011)和 PSM 队列(p=0.017)中,存在 CSPH 的患者总生存率(OS)均低于不存在 CSPH 的患者。PSM 后,多变量 Cox 分析表明 CSPH 是 OS 的独立危险因素(风险比=1.585,95%CI 1.107-2.269;p=0.012)。

结论

CSPH 是肝硬化 ICC 患者手术后 PHLF 和 OS 的重要危险因素。术前选择合适的患者可以有效避免 PHLF,改善 ICC 的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/26922bcd501a/CAM4-10-6985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/b348c3bd8db5/CAM4-10-6985-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/391e07ca5838/CAM4-10-6985-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/26922bcd501a/CAM4-10-6985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/b348c3bd8db5/CAM4-10-6985-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/391e07ca5838/CAM4-10-6985-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b4/8525133/26922bcd501a/CAM4-10-6985-g001.jpg

相似文献

1
Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.门静脉高压症对肝内胆管细胞癌肝切除术后短期和长期结局的影响:倾向评分匹配分析。
Cancer Med. 2021 Oct;10(20):6985-6997. doi: 10.1002/cam4.4222. Epub 2021 Aug 18.
2
Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis.肝功能 A 级肝硬化患者的门静脉高压严重程度与肝切除术后肝功能衰竭的预测。
Br J Surg. 2012 Dec;99(12):1701-10. doi: 10.1002/bjs.8951.
3
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.列线图预测肝内胆管细胞癌切除术后的长期生存:东西方经验。
JAMA Surg. 2014 May;149(5):432-8. doi: 10.1001/jamasurg.2013.5168.
4
A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension.一种用于伴有临床显著门脉高压的肝细胞癌患者的肝切除术的新手术方案。
BMC Cancer. 2024 Jun 25;24(1):764. doi: 10.1186/s12885-024-12535-9.
5
The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.术后肝内胆管癌患者肌少症联合术前纤维蛋白原-白蛋白比值的预后价值:一项多中心前瞻性研究。
Cancer Med. 2021 Jul;10(14):4768-4780. doi: 10.1002/cam4.4035. Epub 2021 Jun 8.
6
Impact of intraoperative blood transfusion on short and long term outcomes after curative hepatectomy for intrahepatic cholangiocarcinoma: a propensity score matching analysis by the AFC-IHCC study group.术中输血对肝内胆管癌根治性肝切除术后短期和长期预后的影响:AFC-IHCC研究组的倾向评分匹配分析
HPB (Oxford). 2017 May;19(5):411-420. doi: 10.1016/j.hpb.2017.01.001. Epub 2017 Jan 22.
7
Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.肝内胆管癌根治性切除术后围手术期输血并不影响无复发生存和总生存率:倾向评分匹配分析。
BMC Cancer. 2017 Nov 14;17(1):762. doi: 10.1186/s12885-017-3745-z.
8
Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.腹腔镜肝切除术治疗伴有临床显著门脉高压的 BCLC 分期 0/A 期肝细胞癌的预后和安全性:一项多中心、倾向评分匹配研究。
Surg Endosc. 2024 Feb;38(2):799-812. doi: 10.1007/s00464-023-10589-7. Epub 2023 Dec 7.
9
Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.术前γ-谷氨酰转移酶与淋巴细胞比值可预测肝切除术后肝内胆管细胞癌患者的长期预后。
World J Gastroenterol. 2020 Apr 7;26(13):1501-1512. doi: 10.3748/wjg.v26.i13.1501.
10
Hepatectomy is associated with survival in intrahepatic cholangiocarcinoma: An observational study by instrumental variable analysis.肝切除术与肝内胆管癌的生存相关:一项基于工具变量分析的观察性研究。
Medicine (Baltimore). 2021 Mar 5;100(9):e24147. doi: 10.1097/MD.0000000000024147.

引用本文的文献

1
A comparative study of machine learning models predicting post-hepatectomy liver failure: Enhancing risk estimation in over 25,000 National Surgical Quality Improvement Program patients.预测肝切除术后肝衰竭的机器学习模型的比较研究:在超过25000名国家外科质量改进计划患者中增强风险评估
Ann Hepatobiliary Pancreat Surg. 2025 Aug 31;29(3):269-278. doi: 10.14701/ahbps.25-046. Epub 2025 Jul 7.
2
Introducing and Validating the Multiphasic Evidential Decision-Making Matrix (MedMax) for Clinical Management in Patients with Intrahepatic Cholangiocarcinoma.介绍并验证用于肝内胆管癌患者临床管理的多相循证决策矩阵(MedMax)。
Cancers (Basel). 2024 Dec 27;17(1):52. doi: 10.3390/cancers17010052.
3

本文引用的文献

1
Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives.呋替尼,一种用于治疗肝内胆管癌的研究药物:现有证据和未来展望。
Expert Opin Investig Drugs. 2021 Apr;30(4):317-324. doi: 10.1080/13543784.2021.1837774. Epub 2020 Oct 25.
2
Developing a Selection-aided Model to Screen Cirrhotic Intrahepatic Cholangiocarcinoma for Hepatectomy.开发一种辅助选择模型以筛选适合肝切除术的肝硬化性肝内胆管癌。
J Cancer. 2020 Jul 25;11(19):5623-5634. doi: 10.7150/jca.46587. eCollection 2020.
3
Surgery for cholangiocarcinoma.
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
肿瘤负担评分和癌胚抗原可预测肝切除术后肝内胆管细胞癌患者的结局:一项多机构分析。
BMC Cancer. 2024 Mar 20;24(1):358. doi: 10.1186/s12885-024-12091-2.
4
Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study.非侵入性评估的门静脉高压分级可预测肝细胞癌患者肝切除术后肝功能衰竭:一项多中心研究
Front Oncol. 2022 Jul 14;12:934870. doi: 10.3389/fonc.2022.934870. eCollection 2022.
胆管癌的外科治疗。
Liver Int. 2019 May;39 Suppl 1(Suppl Suppl 1):143-155. doi: 10.1111/liv.14089.
4
Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients.门静脉高压可预测肝细胞癌患者肝切除术后的短期和长期预后。
Scand J Gastroenterol. 2018 Dec;53(12):1562-1568. doi: 10.1080/00365521.2018.1538386. Epub 2018 Dec 20.
5
Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.临床显著门静脉高压症对肝癌部分肝切除术后结局的影响:系统评价和荟萃分析。
HPB (Oxford). 2019 Jan;21(1):1-13. doi: 10.1016/j.hpb.2018.07.005. Epub 2018 Aug 3.
6
Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.肝硬化对肝内胆管细胞癌患者肝切除术后预后的影响。
Can J Gastroenterol Hepatol. 2017;2017:6543423. doi: 10.1155/2017/6543423. Epub 2017 Nov 12.
7
Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma.肝门部胆管癌患者肝切除术后肝功能衰竭的风险预测。
J Gastroenterol Hepatol. 2018 Apr;33(4):958-965. doi: 10.1111/jgh.13966. Epub 2018 Jan 26.
8
Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.基于超声数据的可切除肝细胞癌患者肝切除术后肝功能衰竭风险个体化预测列线图
Eur Radiol. 2018 Feb;28(2):877-885. doi: 10.1007/s00330-017-4900-2. Epub 2017 Aug 4.
9
Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients.白蛋白-胆红素评分联合剩余肝体积预测乙型肝炎相关肝细胞癌患者肝切除术后肝衰竭。
Liver Int. 2018 Mar;38(3):494-502. doi: 10.1111/liv.13514. Epub 2017 Jul 28.
10
Liver surgery in cirrhosis and portal hypertension.肝硬化和门静脉高压症的肝脏手术
World J Gastroenterol. 2016 Mar 7;22(9):2725-35. doi: 10.3748/wjg.v22.i9.2725.